SPONSORS LIST
Get to know the sponsors who are supporting the Congress
DIAMOND SPONSORS
About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world.
About Roche
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.
PLATINUM SPONSORs
About Bader Sultan & Brothers Co. W.L.L. (BSBC)
Bader Sultan & Brothers Co. W.L.L. (BSBC) was established in 1960, and has ever since been building a strong reputation as a company premised on growth, holistic solutions, quality control, international operations and corporate social responsibility. Thus, we created a company that covers 360 degrees of excellence.
About Biogen
As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen is also commercializing biosimilars and focusing on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several areas of high unmet need.
About Genpharm
Genpharm is a financially sound privately-owned company based in the Dubai Science Park (DSP), U.A.E. A specialty pharmaceutical company providing partners with fast track market access and sustainable commercial solutions into the Middle East and North Africa (MENA) region and Turkey. We are the preferred regional commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics. We are the first organization to introduce gene therapy in the MENAT Region. We also provide strategic advice on disease areas, product launches, and go to markets strategies. We operate through evidence-based medicine and at the highest ethical standards. Genpharm is driven by a clear purpose. Our employees, associates, and partners take this to heart. It is apparent in our daily work, in every interaction within our communities and with every partnership we forge. We are #BringingCuresToMENATPatients.
GOLD SPONSOR
About Advanced Technology Company
ATC has earned itself an impeccable reputation for setting benchmarks across the Kuwait healthcare and environmental market. This quest for excellence has led ATC to grow exponentially over the last thirty-seven years, to establish itself as a leading partner of choice for all the healthcare and environmental projects in the country.